Analyst Ratings for Cardiome Pharma (CRME)

CRME Rating Summary

CRME Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CRME
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $13.00 (+43.3%) * Over Last 12-Mos
Rating Score: 5 / 10
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
1/8/2015 Brean Capital New Coverage Buy
(N/A)
13.00
(N/A)
9.30 9.07 -2.47% Details
6/17/2014 Mackie Research New Coverage Spec. Buy
(N/A)
9.50
(N/A)
7.01 9.07 29.39% Details
Like CRME Ratings? Also take a look at STDY, NNVC, NURO, NBY

CRME Ratings News